Cargando…

Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms

The lethality neutralization assay in mice is the gold standard for the evaluation of the preclinical efficacy and specification fulfillment of snake antivenoms. However, owing to the animal suffering involved, this assay is a candidate to be replaced by in vitro alternatives or, at least, improved...

Descripción completa

Detalles Bibliográficos
Autores principales: Durán, Gina, Solano, Gabriela, Gómez, Aarón, Cordero, Daniel, Sánchez, Adriana, Villalta, Mauren, Sánchez, Melvin, Díaz, Cecilia, Gutiérrez, José María, León, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634039/
https://www.ncbi.nlm.nih.gov/pubmed/34888521
http://dx.doi.org/10.1016/j.toxcx.2021.100087
_version_ 1784608055344758784
author Durán, Gina
Solano, Gabriela
Gómez, Aarón
Cordero, Daniel
Sánchez, Adriana
Villalta, Mauren
Sánchez, Melvin
Díaz, Cecilia
Gutiérrez, José María
León, Guillermo
author_facet Durán, Gina
Solano, Gabriela
Gómez, Aarón
Cordero, Daniel
Sánchez, Adriana
Villalta, Mauren
Sánchez, Melvin
Díaz, Cecilia
Gutiérrez, José María
León, Guillermo
author_sort Durán, Gina
collection PubMed
description The lethality neutralization assay in mice is the gold standard for the evaluation of the preclinical efficacy and specification fulfillment of snake antivenoms. However, owing to the animal suffering involved, this assay is a candidate to be replaced by in vitro alternatives or, at least, improved by the reduction of the number of animals used per experiment, the introduction of analgesia, and the refinement of the test. Since these tests are usually run for 24 or 48 h, one possibility to refine it is to shorten the endpoint observation time of the assay and so limiting the duration of suffering. To assess the effect of this modification of the standard procedure on the analytical properties of the assay, we compared the median lethal dose (LD(50)) and median effective dose (ED(50)) values, estimated through observation times of 6, 24 and 48 h. We used African and Latin American snake venoms and several batches of two polyspecific antivenoms. A significant correlation was found between LD(50) and ED(50) values estimated at the three observation times. Although some LD(50) and ED(50) values were significantly different at these time points, results of 6 h were robust enough to be used in the characterization of new antivenoms, the verification of specification compliance, and the parallel comparison of formulations. Our observations support the modification of the standard procedures used for assessing neutralizing ability of antivenoms by carrying out the observations at 6 h instead of 24 or 48 h, with the consequent reduction in the suffering inflicted upon mice during these assays. However, the shortening of the observation time in the lethality tests must be validated for each venom and antivenom before its introduction in the routine procedures.
format Online
Article
Text
id pubmed-8634039
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86340392021-12-08 Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms Durán, Gina Solano, Gabriela Gómez, Aarón Cordero, Daniel Sánchez, Adriana Villalta, Mauren Sánchez, Melvin Díaz, Cecilia Gutiérrez, José María León, Guillermo Toxicon X Paper The lethality neutralization assay in mice is the gold standard for the evaluation of the preclinical efficacy and specification fulfillment of snake antivenoms. However, owing to the animal suffering involved, this assay is a candidate to be replaced by in vitro alternatives or, at least, improved by the reduction of the number of animals used per experiment, the introduction of analgesia, and the refinement of the test. Since these tests are usually run for 24 or 48 h, one possibility to refine it is to shorten the endpoint observation time of the assay and so limiting the duration of suffering. To assess the effect of this modification of the standard procedure on the analytical properties of the assay, we compared the median lethal dose (LD(50)) and median effective dose (ED(50)) values, estimated through observation times of 6, 24 and 48 h. We used African and Latin American snake venoms and several batches of two polyspecific antivenoms. A significant correlation was found between LD(50) and ED(50) values estimated at the three observation times. Although some LD(50) and ED(50) values were significantly different at these time points, results of 6 h were robust enough to be used in the characterization of new antivenoms, the verification of specification compliance, and the parallel comparison of formulations. Our observations support the modification of the standard procedures used for assessing neutralizing ability of antivenoms by carrying out the observations at 6 h instead of 24 or 48 h, with the consequent reduction in the suffering inflicted upon mice during these assays. However, the shortening of the observation time in the lethality tests must be validated for each venom and antivenom before its introduction in the routine procedures. Elsevier 2021-11-23 /pmc/articles/PMC8634039/ /pubmed/34888521 http://dx.doi.org/10.1016/j.toxcx.2021.100087 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Paper
Durán, Gina
Solano, Gabriela
Gómez, Aarón
Cordero, Daniel
Sánchez, Adriana
Villalta, Mauren
Sánchez, Melvin
Díaz, Cecilia
Gutiérrez, José María
León, Guillermo
Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
title Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
title_full Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
title_fullStr Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
title_full_unstemmed Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
title_short Assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
title_sort assessing a 6-h endpoint observation time in the lethality neutralization assay used to evaluate the preclinical efficacy of snake antivenoms
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634039/
https://www.ncbi.nlm.nih.gov/pubmed/34888521
http://dx.doi.org/10.1016/j.toxcx.2021.100087
work_keys_str_mv AT durangina assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT solanogabriela assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT gomezaaron assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT corderodaniel assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT sanchezadriana assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT villaltamauren assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT sanchezmelvin assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT diazcecilia assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT gutierrezjosemaria assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms
AT leonguillermo assessinga6hendpointobservationtimeinthelethalityneutralizationassayusedtoevaluatethepreclinicalefficacyofsnakeantivenoms